Вирусология
225 статей · 8 журналов
Журналы подкатегории (8)
- Virology · Elsevier (47)
- Antiviral Research · Elsevier (40)
- Current Opinion in Virology · Elsevier (40)
- Virus Research · Elsevier (40)
- Journal of Virological Methods · Elsevier (34)
- Tumour Virus Research · Elsevier (14)
- Journal of Clinical Virology Plus · Elsevier (10)
- VirusDisease · Springer Nature (0)
-
Antiviral activity of amenamevir alone and in combination with ganciclovir against equine herpesvirus 1
Equine herpesvirus 1 (EHV-1) causes respiratory disease, abortion, and equine herpesvirus myeloencephalopathy (EHM), a neurological disorder characterized by ataxia and hindlimb paralysis. Although EHM remains a major concern in the...
- Inhibition of Porcine Cytomegalovirus/Porcine Roseolovirus (PCMV/PRV) replication with antiviral compounds
- Nucleoside analogs containing an imino-ribitol sugar exhibit a distinctive pattern of interference with RNA synthesis by the Dengue virus polymerase
- Meeting report: 39th International Conference on Antiviral Research in Prague, Czech Republic, April 27–May 1, 2026
- RNA-dependent RNA polymerase (RdRp): Structure, function, and antiviral targeting in RNA viruses
- WG-am combinations restore antiviral potency against fostemsavir and lenacapavir-resistant HIV-1
- Ferritin-displayed engineered sCAR1 nanoparticles as a receptor-decoy antiviral strategy against Coxsackievirus B-associated inflammation
- Corrigendum to “Construction of a suckling mouse model based on an EV-C96 clinical isolate and its application in drug screening and vaccine development” [Antivir. Res. 254 (2026) 106511]
- Editorial - Antibody-based antiviral therapies: a wave of novel approvals is coming up
- Divergent functional checkpoints determine epitope-specific ADE outcomes of SARS-CoV-2 entry
- Novel nirmatrelvir-resistance mutations in SARS-CoV-2 Mpro using a yeast screening platform
- Metabolite screening identifies potent antivirals that mitigate Zika virus-induced ocular pathology
- Nanobodies targeting the conserved post-fusion six-helix bundle core provide protective effects against SARS-CoV-2 infection and immunopathology
- Small molecules inhibit hepatitis B and D virus infection by binding the small surface antigen
- Inarigivir exhibits RIG-I-independent antiviral activity against HBV DNA replication in vitro by inhibiting viral polymerase activity